Seeing the Future: How Alcon’s UNITY® VCS System Is Redefining Eye Surgery

2026 Edison Award Winner | Health, Medical & Biotech — Surgical Robotics & Precision Therapy

As of 2026, cataracts are responsible for almost 45% of global blindness.¹ Behind that statistic is a quieter, more hopeful fact: the majority of cases are preventable or treatable with the right technology in the right hands. For the nearly 28 million people who undergo cataract surgery globally each year — roughly 75,000 every single day — and the millions more who require vitreoretinal procedures to preserve sight threatened by diabetic retinopathy, retinal detachment, or macular disease, the quality of the surgical platform matters enormously.¹ Alcon, the global leader in eye care, is advancing vitreoretinal and cataract surgery with the UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS), the 2026 Edison Award Silver winner in Surgical Robotics & Precision Therapy.

A Convergence That Changes Everything

The premise behind UNITY® VCS is elegantly bold: rather than requiring separate surgical systems for vitreoretinal and cataract procedures, Alcon has unified its best-in-class capabilities for both disciplines into a single, modular platform. The UNITY® VCS handles both anterior segment (cataract) and posterior segment (vitreoretinal) procedures. The UNITY® CS focuses on cataract surgery alone. Together, they represent what Alcon describes as “unprecedented innovation” which is not incremental improvement, but a wholesale rethinking of how ophthalmic surgical systems are designed and deployed.^2-6,*

This matters far beyond the operating room. Cataracts remain the leading cause of blindness globally, responsible for an estimated 45% of all blindness cases worldwide and affecting roughly 94 million people.⁷ The retinal surgery market is growing just as urgently: the global diabetic population surpassed 537 million in 2024, and diabetic retinopathy — a leading cause of blindness among working-age adults — affects an estimated 93 million people worldwide.^8,9 Age-related macular degeneration is projected to affect 288 million people by 2040, up from 196 million in 2020.¹⁰ The demand for skilled, efficient surgical intervention has never been greater, and the tools surgeons use have never mattered more.

Engineering Breakthroughs at Every Level

What distinguishes UNITY® VCS isn’t any single feature, it’s the magnitude and integration of first-to-market innovations working together across a unified platform.

The World’s Fastest Vitrectomy Probe. At the heart of the UNITY® VCS vitreoretinal system is HyperVit® 30K, which is the world’s fastest vitrectomy probe^** that has the capacity to operate at 30,000 cuts per minute (cpm).^6,11,** That’s a 50% increase over its predecessor, Alcon’s own CONSTELLATION® HyperVit® 20K.^6,11 Speed matters because faster cutting reduces the tractional forces applied to the fragile retina during surgery, mitigating the risk of iatrogenic retinal tears and enabling surgeons to work with greater confidence on complex cases.

4D Phacoemulsification: A Leap Forward for Cataract Surgery. The UNITY® 4D Phaco modality is the first and only volumetric phacoemulsification technology of its kind on the market.^{3,±,†,††} Bench data shows it delivers up to 2x faster lens removal than Alcon’s previous OZil® Torsional Phaco^±, while simultaneously depositing 41% less energy^† into the eye.³ This is notable as greater energy introduction during phacoemulsification may be associated with risk of inflammation and cell loss in the inner layer of the cornea.^12,13 Accompanying UNITY® 4D Phaco is Thermal Sentry — a first-of-its-kind energy modulation technology that continuously monitors incision site temperature and automatically adjusts ultrasound power to prevent corneal burns.⁶ It’s the kind of real-time intelligence that transforms a skilled surgeon’s judgment into a system-wide safeguard.

Intelligent Fluidics: Stability You Can Measure. One of the most consequential advances in UNITY® VCS|CS is its Intelligent Fluidics system, which provides proprietary, real-time control of intraocular pressure (IOP), infusion flow, and aspiration flow simultaneously.⁶ For both cataract and vitreoretinal surgery, the system maintains IOP within physiologic variations of the surgeon’s desired setpoint. This level of precision helps create less disruptive surgical conditions and can reduce the stress placed on delicate retinal tissue and the eye overall.^14-16 In cataract surgery, the Intelligent Sentry component demonstrated nearly two times lower occlusion break surge volumes compared to Alcon’s previous CENTURION® system with Active Sentry®, based on bench testing.¹⁷ Surge during occlusion breaks is a key risk factor for anterior chamber instability that can lead to complications like a posterior capsule rupture; reducing it meaningfully can improve surgical safety margins.^15,18

27+ DS Dynamic Stiffener. Micro-incision vitreoretinal surgery (MIVS) has pushed instrumentation to ever-smaller gauge sizes, but smaller probes traditionally sacrifice stiffness and control. Alcon’s UNITY® 27+ DS technology solves this with a Dynamic Stiffener that delivers the performance of 25+ gauge instruments in the smaller 27-gauge footprint.^{4,^} The result is optimized surgical control and reach in a less invasive form factor.

TetraSpot Laser. Completing the platform’s vitreoretinal toolkit, UNITY® TetraSpot is the first and only multi-spot, illuminated laser probe — capable of delivering 1, 2, or 4 laser spots simultaneously, reducing laser application time by up to 3.1 times compared to single-spot delivery.^2,Δ

Designed for the Way Surgeons Actually Work

Innovation in the operating room is only meaningful if surgeons can actually use it. UNITY® VCS|CS was engineered with clinical workflow in mind from the ground up. System setup and teardown time is 25% faster than the CONSTELLATION® Vision System, reducing OR turnover time by approximately 1.5 minutes per posterior segment surgery — a meaningful efficiency gain in high-volume surgical centers.^{19,‡,§,§§} The interface features graphical guided setup, integrated RFID instrument identification, and intuitive controls designed to reduce cognitive load during complex procedures. The platform also connects seamlessly with Alcon’s existing and future surgical equipment ecosystem — positioning UNITY® VCS|CS as the connective tissue of a fully integrated surgical suite.⁶

Alcon’s Commitment to Ending Preventable Blindness

UNITY® VCS doesn’t exist in isolation. It is the latest expression of a decades-long commitment by Alcon to pursue technologies that give surgeons the tools they need to treat and prevent vision loss at scale. The scale of unmet need is sobering: despite approximately 28 million cataract surgeries performed annually, surgical coverage in many countries remains at or below 50%, and in some low-income regions the cataract surgical rate is fewer than 500 procedures per million people per year, compared to over 5,000 in high-income countries.¹ The economic burden of vision impairment is estimated by the World Health Organization at $411 billion annually in lost productivity.²⁰ Technology that supports safety and efficiency doesn’t just benefit individual patients — it expands the capacity of healthcare systems to serve more people with the surgeons and facilities they already have.

The 25% reduction in OR setup time,^‡,§,§§ the improved platform uptime through Alcon Intelligent Services and remote serviceability, the streamlined inventory management through Custom Pak® — each of these operational efficiencies compounds across thousands of surgical centers worldwide, multiplying the platform’s real-world impact.^19,21

Recognized for What It Is: A New Benchmark

The Edison Awards, presented annually since 1987, honor innovations that demonstrate the transformational potential of human ingenuity. Named for Thomas Edison — whose own career was defined by relentless iteration in service of making life better — the awards recognize not just technological achievement, but market-ready solutions that reshape industries and improve lives. Selecting UNITY® VCS in the Surgical Robotics & Precision Therapy category reflects what the platform represents: not an incremental refinement of existing tools, but the establishment of a new benchmark for what ophthalmic surgery can be.

For the surgeons who use it, UNITY® VCS|CS offers capabilities that were simply not available before. For their patients — a 70-year-old grandmother recovering her ability to read, a 50-year-old diabetic patient whose retinal detachment is repaired before permanent damage sets in — the platform represents something more fundamental: support for surgeons treating vision-threatening conditions.

That is the kind of innovation that deserves recognition. And it is the kind of innovation that Alcon has spent decades working to make real.

Learn more about the UNITY® VCS and UNITY® CS at myalcon.com, and explore the full 2026 Edison Awards finalist gallery at edisonawards.com.

© 2026 Alcon Inc. GLB/IMG-UVC-2600018

^* Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data.
^** Compared to Constellation HYPERVIT 20k vitrectomy probe.
^± Trademarks are the property of their respective owners.
^† Based on bench data.
^†† Based on N=10 HPs, Artificial cataract lens IOP 55mmhg vacuum of 450 mmHg.
^{^} Versus Alcon’s Non-Dynamic Stiffener 27+ technology.
^Δ MSLP(4) is 3 times faster than SSLP.
^‡ For posterior segment surgeries/posterior cassette pack.
^§ (P < 0.001).
^§§ ~1.5 minutes faster.

References

1. Dreyer, J. (2026, January 9). Cataract stats. Contact Lenses Plus. https://www.contactlensesplus.com/education/cataract-stats.
2. Alcon data on file, 2024. [REF-24615].
3. Alcon data on file, 2024. [REF-24379].
4. Alcon data on file, 2024. [REF-24576].
5. Alcon data on file, 2024. [REF-24498].
6. UNITY® VCS and CS User Manual, 2024.
7. O’Brart D. The future of cataract surgery. Eye (Lond). 2025 Jun;39(8):1451-1456. doi: 10.1038/s41433-025-03745-x
8. Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee . IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021. Chapter 3, Global picture. https://www.ncbi.nlm.nih.gov/books/NBK581940/.
9. Global Growth Insights. (2026, March 9). Retinal surgery devices market size, share, growth, and industry analysis. https://www.globalgrowthinsights.com/market-reports/retinal-surgery-devices-market-110241.
10. Renub Research. (n.d.). Retinal surgery device market: Global forecast by product, application, end user, countries and company analysis 2026–2034. https://www.renub.com/retinal-surgery-device-market-global-forecast-p.php.
11. Alcon data on file, 2024. [REF-24644].
12. Jiang L et al. BMC Ophthalmol. 2020.
13. Malik PK et al. Eye Vis (Lond). 2017.
14. Alcon data on file, 2025. [REF-24899].
15. Vasavada V et al. J Refract Surg. 2014.
16. Vasavada AR et al. J Cataract Refract Surg. 2010.
17. Alcon data on file, 2025. [REF-25562].
18. Zhao Z et al. Int Ophthalmol. 2020.
19. Alcon data on file, 2024. [REF-25374].
20. World Health Organization. (2026, February 10). Blindness and vision impairment. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment.
21. Ayres BD et al. Clinicoecon Outcomes Res. 2022.

UNITY® VCS and CS Important Product Information

Caution: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

INDICATIONS / INTENDED USE:

UNITY® VCS:
The UNITY® VCS console, when used with compatible devices, is indicated for use during anterior segment (i.e. phacoemulsification and removal of cataracts) and posterior segment (i.e., vitreoretinal) ophthalmic surgery.

In addition, with the optional laser this system is indicated for photocoagulation (i.e., vitreoretinal and macular pathologies), iridotomy and trabeculoplasty procedures.

UNITY® CS:
The UNITY® CS console, when used with compatible devices, is indicated for use during anterior segment (i.e., phacoemulsification and removal of cataracts) ophthalmic surgery.

Warnings:
Appropriate use of UNITY® VCS and CS parameters and accessories is important for successful procedures. The console supports various accessories to perform various surgical procedures.

Accessories include handpieces and probes, as well as tips and sleeves when necessary. Different accessories are required for different procedures and operating modes.

Test for adequate irrigation and aspiration flow, reflux, and operation of each accessory prior to entering the eye.

The consumables used in conjunction with ALCON® instrument products constitute a complete surgical system. To avoid the risk of a patient hazard, do not mismatch consumable components or use settings not specifically adjusted for particular consumable component combinations.

AEs/Complications:
Inadvertent activation of functions that are intended for priming or tuning accessories while the accessory is in the eye can create a hazardous situation that could result in patient injury.

During any ultrasonic procedure, metal particles may result from inadvertent touching of the ultrasonic tip with a second instrument. Another potential source of metal particles resulting from any ultrasonic handpiece may be the result of ultrasonic energy causing micro abrasion of the ultrasonic tip.

ATTENTION: Refer to the Directions for Use for the accessories/consumables and User Manual for a complete listing of indications, warnings, cautions and notes.

© 2026 Alcon Inc. GLB/IMG-UVC-2600018